share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

Hong Kong Stock Exchange ·  Apr 26 16:35
Summary by Futu AI
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月26日期間，進行了多次A股股份回購。根據公司提交的翌日披露報表，公司在上述期間內共回購了數百萬股份，每次回購的股份數目及發生變動的日期均有詳細記錄。回購價格與市價相比，有時呈現折讓，有時則為溢價。該系列股份回購行動是根據香港聯合交易所有限公司證券上市規則以及上海證券交易所的相關規則進行的。最後一次回購發生在2024年4月26日，當日公司回購了470,500股A股股份。此外，公司確認所有回購活動均已符合相關法律規定，並已獲得董事會的正式授權。
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月26日期間，進行了多次A股股份回購。根據公司提交的翌日披露報表，公司在上述期間內共回購了數百萬股份，每次回購的股份數目及發生變動的日期均有詳細記錄。回購價格與市價相比，有時呈現折讓，有時則為溢價。該系列股份回購行動是根據香港聯合交易所有限公司證券上市規則以及上海證券交易所的相關規則進行的。最後一次回購發生在2024年4月26日，當日公司回購了470,500股A股股份。此外，公司確認所有回購活動均已符合相關法律規定，並已獲得董事會的正式授權。
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 26, 2024. According to the Company's Next Day Disclosure Report, the Company has repurchased millions of shares during the above period, with a detailed record of the number of shares repurchased and the date of the change. The repurchase price is sometimes a discount compared to the market price, and sometimes it is a premium. This series of share repurchases is carried out in accordance with the Listing Rules of the Hong Kong Stock Exchange Limited and the relevant rules of the Shanghai Stock Exchange. The last repurchase took place on April 26, 2024, on which day the company repurchased 470,500 shares of A-shares. In addition, the Company confirms that all repurchase activities are in compliance with the relevant legal requirements and have been formally authorized by the Board of Directors.
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 26, 2024. According to the Company's Next Day Disclosure Report, the Company has repurchased millions of shares during the above period, with a detailed record of the number of shares repurchased and the date of the change. The repurchase price is sometimes a discount compared to the market price, and sometimes it is a premium. This series of share repurchases is carried out in accordance with the Listing Rules of the Hong Kong Stock Exchange Limited and the relevant rules of the Shanghai Stock Exchange. The last repurchase took place on April 26, 2024, on which day the company repurchased 470,500 shares of A-shares. In addition, the Company confirms that all repurchase activities are in compliance with the relevant legal requirements and have been formally authorized by the Board of Directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.